These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37429682)

  • 1. Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trial.
    Kamperman RG; Bogaards JA; Evers SW; Walter HAW; de Visser M; de Borgie C; Colen-de Koning JCA; Verhamme C; Maas M; Eftimov F; van Schaik IN; van der Kooi AJ; Raaphorst J
    BMJ Open; 2023 Jul; 13(7):e067435. PubMed ID: 37429682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
    Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).
    Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F;
    Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.
    Gandiga PC; Ghetie D; Anderson E; Aggrawal R
    Curr Rheumatol Rep; 2023 Aug; 25(8):152-168. PubMed ID: 37261663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin for multifocal motor neuropathy.
    Keddie S; Eftimov F; van den Berg LH; Brassington R; de Haan RJ; van Schaik IN
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD004429. PubMed ID: 35015296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
    Aggarwal R; Charles-Schoeman C; Schessl J; Dimachkie MM; Beckmann I; Levine T
    Medicine (Baltimore); 2021 Jan; 100(1):e23677. PubMed ID: 33429735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.
    Dalakas MC; Koffman B; Fujii M; Spector S; Sivakumar K; Cupler E
    Neurology; 2001 Feb; 56(3):323-7. PubMed ID: 11171896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
    Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
    J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids for the treatment of Duchenne muscular dystrophy.
    Matthews E; Brassington R; Kuntzer T; Jichi F; Manzur AY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003725. PubMed ID: 27149418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis.
    Giannini M; Fiorella ML; Tampoia M; Girolamo F; Fornaro M; Amati A; Lia A; Abbracciavento L; D'Abbicco D; Iannone F
    Rheumatology (Oxford); 2021 Mar; 60(3):1234-1242. PubMed ID: 32911543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for necrotizing soft tissue infections in adults.
    Hua C; Bosc R; Sbidian E; De Prost N; Hughes C; Jabre P; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011680. PubMed ID: 29851032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathies.
    Anang DC; Walter HAW; Lim J; Niewold I; van der Weele L; Aronica E; Eftimov F; Raaphorst J; van Schaik BDC; van Kampen AHC; van der Kooi AJ; de Vries N
    Rheumatology (Oxford); 2023 Jul; 62(7):2585-2593. PubMed ID: 36321862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OptimisAtion of Diagnostic Accuracy in idioPathic inflammaTory myopathies (ADAPT study): a protocol for a prospective diagnostic accuracy study of multimodality testing in patients suspected of a treatable idiopathic inflammatory myopathy.
    Walter HAW; Kamperman RG; Raaphorst J; Verhamme C; Koelman JHTM; Potters WV; Hemke R; Smithuis FF; Aronica E; van Leeuwen EMM; Baars PA; de Visser M; van Schaik IN; Bossuyt PMM; van der Kooi AJ
    BMJ Open; 2021 Dec; 11(12):e053594. PubMed ID: 34903547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study.
    Lim J; Eftimov F; Verhamme C; Brusse E; Hoogendijk JE; Saris CGJ; Raaphorst J; De Haan RJ; van Schaik IN; Aronica E; de Visser M; van der Kooi AJ
    Rheumatology (Oxford); 2021 Apr; 60(4):1784-1792. PubMed ID: 33099648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin for the treatment of childhood encephalitis.
    Iro MA; Martin NG; Absoud M; Pollard AJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study.
    Dalakas MC; Sonies B; Dambrosia J; Sekul E; Cupler E; Sivakumar K
    Neurology; 1997 Mar; 48(3):712-6. PubMed ID: 9065553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.